Cancer Research Cancer Health Disparities Conference 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hao, J.-H.
Right arrow Articles by Jia, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hao, J.-H.
Right arrow Articles by Jia, L.
[Cancer Research 64, 3607-3616, May 15, 2004]
© 2004 American Association for Cancer Research


Regular Articles

Bcl-2 Inhibitors Sensitize Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand-Induced Apoptosis by Uncoupling of Mitochondrial Respiration in Human Leukemic CEM Cells

Ji-Hui Hao1, Ming Yu1,2, Feng-Ting Liu1, Adrian C. Newland1 and Li Jia1

1 Department of Haematology, Barts and The London Queen Mary’s School of Medicine and Dentistry, London, United Kingdom, and 2 Tianjin Medical University, Tianjin, People’s Republic of China.

Previous studies have shown that the lymphoblastic leukemia CEM cell line is resistant to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis because of a low expression of caspase-8. Bcl-2 inhibitors, BH3I-2' and HA14-1, are small cell-permeable nonpeptide compounds, are able to induce apoptosis by mediating cytochrome c release, and also lead to dissipation of the mitochondrial membrane potential ({Delta}{Psi}m). This study aimed to use the Bcl-2 inhibitors to sensitize CEM cells to TRAIL-induced apoptosis by switching on the mitochondrial apoptotic pathway. We found that a low dose of BH3I-2' or HA14-1, which did not induce cytochrome c release, greatly sensitized CEM cells to TRAIL-induced apoptosis. In a similar manner to the classical uncoupler carbonyl cyanide m-chlorophenylhydrazone (CCCP), both BH3I-2' and HA14-1 induced a reduction in {Delta}{Psi}m, a generation of reactive oxygen species (ROS), an increased mitochondrial respiration, and a decreased ATP synthesis. This uncoupling function of the Bcl-2 inhibitors was responsible for the synergy with TRAIL-induced apoptosis. CCCP per se did not induce apoptosis but again sensitized CEM cells to TRAIL-induced apoptosis by uncoupling mitochondrial respiration. The uncoupling effect facilitated TRAIL-induced Bax conformational change and cytochrome c release from mitochondria. Inhibition of caspases failed to block TRAIL-mediated cell death when mitochondrial respiration was uncoupled. We observed that BH3I-2', HA14-1, or CCCP can overcome resistance to TRAIL-induced apoptosis in TRAIL-resistant cell lines, such as CEM, HL-60, and U937. Our results suggest that the uncoupling of mitochondrial respiration can sensitize leukemic cells to TRAIL-induced apoptosis. However, caspase activation per se does not represent an irreversible point of commitment to TRAIL-induced cell death when mitochondrial respiration is uncoupled.




This article has been cited by other articles:


Home page
BloodHome page
F.-T. Liu, S. G. Agrawal, Z. Movasaghi, P. B. Wyatt, I. U. Rehman, J. G. Gribben, A. C. Newland, and L. Jia
Dietary flavonoids inhibit the anticancer effects of the proteasome inhibitor bortezomib
Blood, November 1, 2008; 112(9): 3835 - 3846.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
F.-T. Liu, S. G. Agrawal, J. G. Gribben, H. Ye, M.-Q. Du, A. C. Newland, and L. Jia
Bortezomib blocks Bax degradation in malignant B cells during treatment with TRAIL
Blood, March 1, 2008; 111(5): 2797 - 2805.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
B. S. Prabhakar, N. Mulherkar, and K. V. Prasad
Role of IG20 Splice Variants in TRAIL Resistance
Clin. Cancer Res., January 15, 2008; 14(2): 347 - 351.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
L. Emdad, I. V. Lebedeva, Z.-Z. Su, D. Sarkar, P. Dent, D. T. Curiel, and P. B. Fisher
Melanoma differentiation associated gene-7/interleukin-24 reverses multidrug resistance in human colorectal cancer cells
Mol. Cancer Ther., November 1, 2007; 6(11): 2985 - 2994.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
F. H. Psahoulia, K. G. Drosopoulos, L. Doubravska, L. Andera, and A. Pintzas
Quercetin enhances TRAIL-mediated apoptosis in colon cancer cells by inducing the accumulation of death receptors in lipid rafts
Mol. Cancer Ther., September 1, 2007; 6(9): 2591 - 2599.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
G. Kroemer, L. Galluzzi, and C. Brenner
Mitochondrial Membrane Permeabilization in Cell Death
Physiol Rev, January 1, 2007; 87(1): 99 - 163.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
W.-S. Yeow, A. Baras, A. Chua, D. M. Nguyen, S. S. Sehgal, D. S. Schrump, and D. M. Nguyen
Gossypol, a phytochemical with BH3-mimetic property, sensitizes cultured thoracic cancer cells to Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand
J. Thorac. Cardiovasc. Surg., December 1, 2006; 132(6): 1356 - 1362.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
H.-M. Shen and S. Pervaiz
TNF receptor superfamily-induced cell death: redox-dependent execution
FASEB J, August 1, 2006; 20(10): 1589 - 1598.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. Milanesi, P. Costantini, A. Gambalunga, R. Colonna, V. Petronilli, A. Cabrelle, G. Semenzato, A. M. Cesura, E. Pinard, and P. Bernardi
The Mitochondrial Effects of Small Organic Ligands of BCL-2: SENSITIZATION OF BCL-2-OVEREXPRESSING CELLS TO APOPTOSIS BY A PYRIMIDINE-2,4,6-TRIONE DERIVATIVE
J. Biol. Chem., April 14, 2006; 281(15): 10066 - 10072.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
F. Manero, F. Gautier, T. Gallenne, N. Cauquil, D. Gree, P.-F. Cartron, O. Geneste, R. Gree, F. M. Vallette, and P. Juin
The Small Organic Compound HA14-1 Prevents Bcl-2 Interaction with Bax to Sensitize Malignant Glioma Cells to Induction of Cell Death.
Cancer Res., March 1, 2006; 66(5): 2757 - 2764.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
K. Izeradjene, L. Douglas, D. M. Tillman, A. B. Delaney, and J. A. Houghton
Reactive Oxygen Species Regulate Caspase Activation in Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand-Resistant Human Colon Carcinoma Cell Lines
Cancer Res., August 15, 2005; 65(16): 7436 - 7445.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
Y. Liu, G. L. Borchert, S. P. Donald, A. Surazynski, C.-A. Hu, C. J. Weydert, L. W. Oberley, and J. M. Phang
MnSOD inhibits proline oxidase-induced apoptosis in colorectal cancer cells
Carcinogenesis, August 1, 2005; 26(8): 1335 - 1342.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
M. Konopleva, E. Elstner, T. J. McQueen, T. Tsao, A. Sudarikov, W. Hu, W. D. Schober, R.-Y. Wang, D. Chism, S. M. Kornblau, et al.
Peroxisome proliferator-activated receptor {gamma} and retinoid X receptor ligands are potent inducers of differentiation and apoptosis in leukemias
Mol. Cancer Ther., October 1, 2004; 3(10): 1249 - 1262.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2004 by the American Association for Cancer Research.